Discovery of essential proteins using a heavy chain, single polypeptide mini-antibody platform provided by Madrid, Spain-based Bacmine SL, and its Innovators, Pablo Pomposiello, PhD, and Victor de Lorenzo, PhD. Open Therapeutics will freely provide the global community with the essential proteins that pathogens (disease causing organisms) and cancer cells require to survive. By characterizing essential proteins, the global community can collaboratively develop antibiotics to target the cells. In addition to the first release of E. coli essential proteins, Drs. Pomposiello, Su, Guo, and Cripe are working toward discovering and freely providing additional essential proteins to the global science community.
Want to save these project details? Download this brief Project Manifest for your convenience!